Potential misdiagnosis of von Willebrand disease and haemophilia caused by ineffective mixing of thawed plasma
暂无分享,去创建一个
G. Lippi | E. Favaloro | G. Lima-Oliveira | S. Oliver | S. Mohammed | M. Ahuja | E. Grzechnik | S. Azimulla | J. McDonald
[1] E. Favaloro,et al. Evaluation of a new commercial von Willebrand factor multimer assay , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.
[2] Giuseppe Lippi,et al. Pre-analytical phase management: a review of the procedures from patient preparation to laboratory analysis , 2017, Scandinavian journal of clinical and laboratory investigation.
[3] S. Kitchen,et al. Factor Activity Assays for Monitoring Extended Half-Life FVIII and Factor IX Replacement Therapies , 2017, Seminars in Thrombosis and Hemostasis.
[4] E. Favaloro. Utility of the von Willebrand factor collagen binding assay in the diagnosis of von Willebrand disease , 2017, American journal of hematology.
[5] D. Adcock,et al. Factor VIII Activity and Inhibitor Assays in the Diagnosis and Treatment of Hemophilia A , 2016, Seminars in Thrombosis and Hemostasis.
[6] G. Lippi,et al. Mixing of thawed coagulation samples prior to testing: Is any technique better than another? , 2016, Clinical biochemistry.
[7] E. Favaloro,et al. Laboratory tests used to help diagnose von Willebrand disease: an update. , 2016, Pathology.
[8] E. Favaloro,et al. Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease. , 2016, Thrombosis research.
[9] G. Lippi,et al. Does fist pumping/clenching during venipuncture activate blood coagulation? , 2016, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[10] V. Blanchette,et al. Definitions in Hemophilia: Resolved and Unresolved Issues , 2015, Seminars in Thrombosis & Hemostasis.
[11] G. Lippi,et al. Influence of posture on routine hemostasis testing , 2015, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[12] G. Lippi,et al. The Changing Face of Hemostasis Testing in Modern Laboratories: Consolidation, Automation, and Beyond , 2015, Seminars in Thrombosis & Hemostasis.
[13] E. Favaloro,et al. Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays. , 2014, Thrombosis research.
[14] R. Tait,et al. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology , 2014, British journal of haematology.
[15] E. Duncan,et al. Evaluating errors in the laboratory identification of von Willebrand disease in the real world. , 2014, Thrombosis research.
[16] J. Rand,et al. Current Diagnostic and Therapeutic Approaches to Patients with Acquired von Willebrand Syndrome: A 2013 Update , 2013, Seminars in Thrombosis & Hemostasis.
[17] G. Lippi,et al. Quality Standards for Sample Processing, Transportation, and Storage in Hemostasis Testing , 2012, Seminars in Thrombosis & Hemostasis.
[18] G. Lippi,et al. Quality Standards for Sample Collection in Coagulation Testing , 2012, Seminars in Thrombosis & Hemostasis.
[19] E. Favaloro,et al. Differential sensitivity of von Willebrand factor (VWF) ‘activity’ assays to large and small VWF molecular weight forms: a cross‐laboratory study comparing ristocetin cofactor, collagen‐binding and mAb‐based assays , 2012, Journal of thrombosis and haemostasis : JTH.
[20] Giuseppe Lippi,et al. Pre-analytical Variables in Coagulation Testing Associated With Diagnostic Errors in Hemostasis , 2012 .
[21] E. Favaloro,et al. von Willebrand Disease: Local Diagnosis and Management of a Globally Distributed Bleeding Disorder , 2011, Seminars in thrombosis and hemostasis.